Director purchased ~$870K of ELV shares in the open market

Not enough history to judge

Confirmed open-market purchases by the same insider in the available history

No other insider purchases within 30 days

Distinct insiders at the same issuer with confirmed open-market purchases

36 days after results of Jan 28, 2026, 48 days before results of Apr 22, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Closed at $286.48 on Mar 5, 2026, within 5% of its 52-week low, after a 23% drop over the previous 30 trading days

52-week range $274.66 (Aug 1, 2025) to $452.69 (Apr 3, 2025), 7% of the way up, from 251 adjusted closes. 30 trading days earlier: $369.88 on Jan 21, 2026. Describes the past only, not a forecast

None found in footnotes

Only flagged when a footnote says so; never inferred

A securities lawsuit naming the company as a defendant was filed on May 12, 2025 in the U.S. District Court, S.D. Indiana. A filing is an allegation, not a finding.

MILLER v. ELEVANCE HEALTH, INC., docket 1:25-cv-00923, via CourtListener (court records). Nature of suit 850, company named as first defendant